What is the main business of Holcard?

The main business activity of Holcard focuses on other human health activities not elsewhere classified.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 13, 2016.

Where is the headquarters located?

The headquarters is located at: ul. Panewnicka 113, 40-761 Katowice.

Who is on the management board?

The management board includes Stanisław Andrzej Trznadel (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 10,000 (approx. $2,701).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

How much revenue was generated?

The company reported a revenue of $3,463 in 2023, which is a decrease of 51.8% compared to 2022.

No, in 2023 the company was not profitable, reporting a net loss of $2,621.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $6,000 in 2023, representing 99% of all operating expenses.

Holcardsp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2016-12-13

Share capital

10,000.00 PLN

Activity description

Holcard Sp. z o.o. provides remote interpretation of Holter tests, including Holter ECG, for the medical sector. Reports are prepared around the clock, and results may be available on the Web Holcard platform within 3 hours of test submission.

Registered address

ul. Panewnicka 113, 40-761 Katowice, Poland

Website

holcard.pl

Phone

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 563 days for 2018).

2024not filed
202331/07/2024
202228/06/2023
202113/10/2022
202013/10/2021
201914/10/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue

This companyUSD 3.46kMedianUSD 91.87kAverageUSD 1.38m

Net profit

This companyUSD -2.62kMedianUSD 2.66kAverageUSD 145.77k

Operating costs

This companyUSD 6.06kMedianUSD 82.72kAverageUSD 1.18m

Assets

This companyUSD 11.23kMedianUSD 39.38kAverageUSD 949.95k

Industry

Other human health activities not elsewhere classified (86.90.E)Primary

Offer

Holter examination reporting
ECG recording interpretation
Remote examination analysis
Holter examination reports
Telemedicine platform

Authorized Representatives

Stanisław Andrzej Trznadel – Management Board Member

Paweł Ryszard Chabiński – President of the Management Board

Manner of representation

In the case of a one-person management board, declarations of will on behalf of the company are made by a member of the management board. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Paweł Ryszard Chabińskiage 43	49	$1,323.61	49%
Stanisław Andrzej Trznadelage 60	51	$1,377.63	51%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

	Name	Revenue	Website
	Coralis Medsp. z o.o.	$10,656.96	coralismed.pl

FAQ

Last updated: 2026-04-20